Advertisement

Nichtalkoholische Leberverfettungen und Steatohepatitiden

  • H. Dancygier
Chapter

Zusammenfassung

Das Spektrum nichtalkoholischer Leberverfettungen (non alcoholic fatty liver disease) reicht von der blanden Steatose über die Steatohepatitis, Steatofibrose bis zur Leberzirrhose. Bei Unkenntnis der vielfältigen Ursachen dieses klinisch-pathologischen Syndroms kann allein aufgrund des histopathologischen Befundes einem Patienten fälschlicherweise Alkoholmissbrauch unterstellt werden. Die ungerechtfertigte Diagnose einer alkoholischen Lebererkrankung kann für die/den Betroffene(n) gravierende soziale, juristische und versicherungsmedizinische Folgen haben. Darüber hinaus können nichtalkoholische Leberverfettungen, wenn sie mit nekroinflammatorischen Läsionen und Fibrose einhergehen, bei bestimmten Patienten Ursache einer Leberzirrhose sein. Daher ist die Kenntnis dieser Schädigungen wichtig und die Einordnung nichtalkoholischer Leberverfettungen als eigene nosologische Entität gerechtfertigt.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Adler M, Schaffner F (1979) Fatty liver hepatitis and cirrhosis in obese patients. Amer J Med 67: 811–816PubMedCrossRefGoogle Scholar
  2. Andersen T, Gloud C, Franzman MB et al. (1991) Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol 12: 224–229PubMedCrossRefGoogle Scholar
  3. Angulo P, Keach JC, Batts et al. (1999) Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30: 1356–1362PubMedCrossRefGoogle Scholar
  4. Auwerx J, Staels B (1998) Leptin. Lancet 351: 737–742PubMedCrossRefGoogle Scholar
  5. Bacon BR, Farahvash MJ, Janney CG et al. (1994) Nonalcoholic steatohepatitis. An expanded clinical entity. Gastroenterology 107: 1103–1109PubMedGoogle Scholar
  6. Baldridge AD, Perez-Atayde AR, Graeme-Cook F et al. (1995) Idiopathic steatohepatitis in childhood. A multicenter retrospective study. J Pediatr 127: 700–704PubMedCrossRefGoogle Scholar
  7. Bellentani S, Saccoccio G, Masutti F et al. (2000) Prevalence of and risk factors for hepatic steatosis in northern Italy. Ann Intern Med 132: 112–117PubMedGoogle Scholar
  8. Bonkovsy HL, Jawaid Q, Tortorelli K et al. (1999) Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol 31:421–429Google Scholar
  9. Brolin RE, Bradley LJ, Taliwal RV (1998) Unsuspected cirrhosis discovered during obesity operations. Arch Surg 133: 84–88PubMedCrossRefGoogle Scholar
  10. Brunt EM, Janney CG, Di Bisceglie AM et al. (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histologicallesions. Am J Gastroenterol 94: 2467–2474PubMedCrossRefGoogle Scholar
  11. Bugianesi E, Leone N, Vanni E et al. (2002) Expanding the natural history or nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123: 134–140PubMedCrossRefGoogle Scholar
  12. Byron D, Minuk GY (1996) Clinical hepatology. Profile of an urban, hospital-based practice. Hepatology 24: 813–815PubMedCrossRefGoogle Scholar
  13. Cairns SR, Kark AE, Peters TJ (1986) Raised hepatic free fatty acids in a patient with acute fatty liver after gastric surgery for morbid obesity. J Clin Pathol 39: 647–649PubMedCrossRefGoogle Scholar
  14. Caldwell SH, Oelsner DH, Iezzoni JC et al. (1999) Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 29: 664–669PubMedCrossRefGoogle Scholar
  15. Dancygier H (1990) Alkoholische Leberschäden. Krankenhausarzt 63: 670–674Google Scholar
  16. Dancygier H (1997) „Alkoholische“ Leberschäden bei Nichtalkoholikern. Die nichtalkoholische Steatohepatitis. Dtsch Med Wochenschr 122: 1183–1188PubMedCrossRefGoogle Scholar
  17. Dancygier H (1998) Fettleber. In: Classen M, Diehl V, Kochsiek K (Hrsg) Innere Medizin, 4. Aufl. Urban & Schwarzenberg, München, S 693–697Google Scholar
  18. Dancygier H (2001) Die nichtalkoholische Steatohepatitis. Dtsch Årztebl 98: A 2511–2516Google Scholar
  19. Day CP, James OFW (1998) Hepatic steatosis: innocent bystander or guilty party? Hepatology 27: 1463–1466PubMedCrossRefGoogle Scholar
  20. Diehl AM, Goodman Z, Ishak KG (1988) Alcohol-like liver disease in nonalcoholics. A clinical and histological comparison with alcohol induced liver injury. Gastroenterology 95: 1056–1062PubMedGoogle Scholar
  21. Dixon JB, Bhathal PS, O’Brien PE (2001) Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121: 91–100PubMedCrossRefGoogle Scholar
  22. Falck-Ytter Y, Younossi ZM, Marchesini G et al. (2001) Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 21: 17–26PubMedCrossRefGoogle Scholar
  23. Fletcher LM, Keroh-Gain J, Powell EE et al. (1991) Markers of chronic alcohol ingestion in patients with nonalcoholic steatohepatitis. An aid to diagnosis. Hepatology 13: 445–449CrossRefGoogle Scholar
  24. Garcia-Monzon C, Martin-Perez E, Lo Iacono O et al. (2000) Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol 33: 7l6–724CrossRefGoogle Scholar
  25. George DK, Goldwurm S, MacDonald GA et al. (1998) Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 114: 311–318PubMedCrossRefGoogle Scholar
  26. Hamilton DL, Vest TK, Brown BS et al. (1983) Liver injury with alcoholic-like hyalin after gastroplasty for morbid obesity. Gastroenterology 85: 722–726PubMedGoogle Scholar
  27. Herlong HF (1994) Approach to the patient with abnormal liver enzymes. Hosp Pract 11: 32–38Google Scholar
  28. Hickman J, Clouston AD, Macdonald GA et al. (2002) Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut 51: 89–94PubMedCrossRefGoogle Scholar
  29. Hilden M, Christofferson P, Juhl E et al. (1977) Liver histology in an “normal” population — examinations of 503 consecutive fatal traffic casualties. Scand J Gastroeneterol 12: 593–597CrossRefGoogle Scholar
  30. Hocking MP, Duerson MC, O’Leary JP et al. (1983) Jejunoileal bypass for morbid obesitiy. Late follow up in 100 cases. N Engl J Med 308: 995–999PubMedCrossRefGoogle Scholar
  31. Honda H, Ikejima K, Hirose M et al. (2002) Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver. Hepatology 36: 12–21PubMedCrossRefGoogle Scholar
  32. Hourigan LF, Macdonald GA, Purdi D et al. (1999) Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 29: 1215–1219PubMedCrossRefGoogle Scholar
  33. Ikejima K, Honda H, Yoshikawa M et al. (2001) Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals. Hepatology 34: 288–297PubMedCrossRefGoogle Scholar
  34. James OFW, Day CP (1998) Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol 29: 495–501PubMedCrossRefGoogle Scholar
  35. Jia DM, Tabaru A, Akiyama T et al. (2000) Fatty liver, chronic viral hepatitis and autoimmune hepatitis. Troglitazone prevents fatty changes of the liver in obese diabetic rats. J Gastroenterol Hepatol 15: 1183–1191PubMedCrossRefGoogle Scholar
  36. Klain J, Fraser D, Goldstein J et al. (1989) Liver histology abnormalities in the morbidly obese. Hepatology 10: 873–876PubMedCrossRefGoogle Scholar
  37. Laurin J, Lindor KD, Crippin JF et al. (1996) Ursodeoxycholic acid or clofibrate in the treatment of nonalcoholic steatohepatitis. A pilot study. Hepatology 23: 1464–1467PubMedCrossRefGoogle Scholar
  38. Leclercq IA, Farrell GC, Field J et al. (2000) CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 105: 1067–1075PubMedCrossRefGoogle Scholar
  39. Lee RG (1989) Nonalcoholic steatohepatitis. A study of 49 patients. Hum Pathol 20: 594–598PubMedCrossRefGoogle Scholar
  40. Lewis JH, Ranard RC, Caruso A et al. (1989) Amiodarone hepatotoxicity. Prevalence and clinico-pathologic correlations among 104 patients. Hepatology 9: 679–685PubMedCrossRefGoogle Scholar
  41. Lonardo A (1999) Fatty liver and nonalcoholic steatohepatitis. Where do we stand and where are we going? Dig Dis 17: 80–89PubMedCrossRefGoogle Scholar
  42. Ludwig J, Viggiano TR, McGill DB et al. (1980) Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55: 434–438PubMedGoogle Scholar
  43. Matteoni CA, Younossi ZM, Gramlich T et al. (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116: 1413–1419PubMedCrossRefGoogle Scholar
  44. McCullough AJ, Falck-Ytter Y (1999) Body composition and hepatic steatosis as precursors for fibrotic liver disease. Hepatology 29: 1328–1330PubMedCrossRefGoogle Scholar
  45. Monto A, Alonzo J, Watson JJ et al. (2002) Steatosis in chronic hepatitis C: relative conributions of obesity, diabetes mellitus, and alcohol. Hepatology 36: 729–736PubMedCrossRefGoogle Scholar
  46. Naveau S, Giraud V, Boretto A et al. (1997) Excess weight risk factor for alcoholic liver disease. Hepatology 25: 108–111PubMedCrossRefGoogle Scholar
  47. Ong JP, Younossi ZM, Speer C et al. (2001) Chronic hepatitis C and superimposed nonalcoholic fatty liver disease. Liver 21: 266–271PubMedCrossRefGoogle Scholar
  48. Palmer M, Shaffner F (1990) Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology 99: 1408–1413PubMedGoogle Scholar
  49. Peura DA, Stromeyer FW, Johnson LF (1980) Liver injury with alcoholic hyalin after intestinal resection. Gastroenterology 79: 128–130PubMedGoogle Scholar
  50. Pinto HC, Baptista A, Camilo ME et al. (1996) Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci 41: 172–179PubMedCrossRefGoogle Scholar
  51. Poucell S, Ireton J, Valencia-Mayoral P et al. (1984) Amiodarone-associated phospholipidosis and fibrosis of the liver. Gastroenterology 86: 926–936PubMedGoogle Scholar
  52. Powell EE, Cooksley WG, Hanson R et al. (1990) The natural history of nonalcoholic steatohepatitis. A follow-up study of forty-two patients for up to 21 years. Hepatology 11: 74–80PubMedCrossRefGoogle Scholar
  53. Propst A, Propst T, Judmaier G et al. (1995) Prognosis in nonalcoholic steatohepatitis. Gastroenterology 108: 1607PubMedCrossRefGoogle Scholar
  54. Reid AE (2001) Nonalcoholic steatohepatitis. Gastroenterology 121: 7l0–723CrossRefGoogle Scholar
  55. Rogers DW, Lee CH, Pound DC et al. (1992) Hepatitis C virus does not cause nonalcoholic steatohepatitis. Dig Dis Sci 37: 1644–1647PubMedCrossRefGoogle Scholar
  56. Rubia-Brandt L, Quadri R, Abid K et al. (2000) Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol 33: 106–115CrossRefGoogle Scholar
  57. Saxena NK, Ikeda K, Rockey DC et al. (2002) Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology 35: 762–771PubMedCrossRefGoogle Scholar
  58. Seki K, Minami Y, Nishikawa M et al. (1983) “Nonalcoholic steatohepatitis” induced by massive doses of synthetic estrogen. Gastroenterol Jpn 18: 197–203PubMedGoogle Scholar
  59. Silverman JF, Pories WJ, Caro JF (1989) Liver pathology in diabetes mellitus and morbid obesity. Clinical, pathological and biochemical considerations. Pathol Ann 24: 275–302Google Scholar
  60. Stone BG, van Thiel DH (1985) Diabetes mellitus and the liver. Semin Liver Dis 5: 8–28PubMedCrossRefGoogle Scholar
  61. Teli MR, James OFW, Burt AD et al. (1995) The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 22: 1714–1719PubMedCrossRefGoogle Scholar
  62. Tilg H, Diehl AM (2000) Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 343: 1467–1476PubMedCrossRefGoogle Scholar
  63. Uygun A, Kadayifci A, Yesilova Z et al. (2000) Serum leptin levels in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 95: 3584–3589PubMedCrossRefGoogle Scholar
  64. Van Ness MM, Diehl AM (1989) Is liver biosy useful in the evaluation of patients with chronically elevated liver enzymes? Ann Intern Med 111: 473–478PubMedGoogle Scholar
  65. Wanless IR, Lentz JS (1990) Fatty liver hepatitis (steatohepatitis) and obesity. An autopsy study with analysis of risk factors. Hepatology 12: 1106–1110PubMedCrossRefGoogle Scholar
  66. Wigg AJ, Roberts-Thomson IC, Dymock RB et al. (2001) The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor a in the pathogenesis of non-alcoholic steatohepatitis. Gut 48: 206–211PubMedCrossRefGoogle Scholar
  67. Willner IR, Waters B, Patil SR et al. (2001) Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol 96: 2957–2961PubMedCrossRefGoogle Scholar
  68. Zeuzem S, Feinman Sv, Rasenack J et al. (2000) Peg interferon alfa-2a in patients with chronic hepatitis C. N Engl J Med 343: 1666–1672PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • H. Dancygier

There are no affiliations available

Personalised recommendations